No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Malin Corporation plc operates as a life sciences firm across Ireland and the United States, primarily through its various subsidiaries. The company specializes in developing and delivering vital solutions for critical medical challenges. Its portfolio includes groundbreaking cell and gene therapies aimed at patients with significant unmet medical requirements. Furthermore, Malin provides treatments targeting pressing needs in oncology, infectious diseases, and autoimmune conditions. It also addresses specific women's health concerns, such as recurrent vulvovaginal candidiasis, and offers remedies for fungal nail infections like onychomycosis. Beyond these, Malin's offerings extend to pharmaceutical products for protein misfolding disorders, a sophisticated platform designed to identify pathogenic bacteria within the gut microbiome, and advanced UV-light disinfection technologies. Additionally, it offers corporate secretarial services. Established in 2014, Malin Corporation plc maintains its headquarters in Dublin, Ireland.
malinplc.comNo one on the platform currently holds MLC.IR.
No tracked institution reports a position in MLC.IR as of their last filing.
No one on the platform has traded MLC.IR yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $0 | — | $-0.12 | $-0.12–$-0.12 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| MLC.IRMalin Corporation plc | $7.00 | +0.00% | $30M | — |
| DHG.IRDalata Hotel Group plc | $6.44 | +0.00% | $1.4B | — |
| GL9.IRGlanbia plc | $21.40 | -0.93% | $5.2B | — |
| IR5B.IRIrish Continental Group plc | $7.94 | +0.25% | $1.2B | — |
| IRES.IRIrish Residential Properties REIT plc | $1.07 | -0.37% | $559M | — |
| UPR.IRUniphar plc | $4.03 | +0.75% | $1.0B | — |
Source: Financial Modeling Prep · peers by sector/industry